Mankind Pharma forays into the Agri-tech industry

New Delhi : Mankind Pharma has announced the launch of Mankind Agritech Pvt Ltd. The company has entered into the ever-growing Indian agri-Input segment to use technological innovations in the field and bring its expertise to Indian farmlands and the Indian agriculture consumers, respectively. The decision behind foraying into this division is to assist Indian farmers by providing new-age technologies and helping farmers for the betterment of the rural sector.

With the launch of Mankind Agritech, the company will be providing crop care solutions to Indian farmers, including weedicides, insecticides, fungicides, plant growth regulators and biologicals. Mankind Agritech will work towards food safety for the country . The company will invest in the new technological tools and aims to deliver the same to the farmers to support them.

Announcing the launch ,Mr Rajeev Juneja, Managing Director and Vice-Chairman, Mankind Pharma said, “We are happy to announce our launch in the Agritech domain with long-term investment plans with an initial 150 to 200 crore Capex infusion in the first two to three years. Mankind Agritech is committed to bring world-class crop protection technology to Indian farmers. Technology is playing a crucial role in ensuring the growth of the agriculture sector in India. Agritech has the potential to scale up the agricultural industry through technological intervention. If the farmers get the right products and tools they would be in a position to make an informed decision of using input and right technology. Mankind Agritech will ensure quality assurance to the farmers.

The new vertical will be headed by Mr Partha Sengupta, a veteran of the Indian agrochemical industry. Mr Partha Sengupta brings in a plethora of experience from the agrochemical industry with over three decades of experience in Sales and Marketing. Mr Sengupta was National Marketing Head and part of the Senior Leadership team at Dhanuka Agritech Limited overseeing Marketing operations in India, Bangladesh, and Nepal.

  • Related Posts

    PGIMS recalls drug amid probe into deaths

    The PGIMS authorities have directed all departments to immediately stop using a specific batch of injectable Propofol, an anaesthetic drug, and return the available stock to the central store. The…

    NPPA list brings little relief: No price cut for 25% cancer drugs

    Mumbai: Nearly one in four cancer drug packs in a revised price list issued by the National Pharmaceutical Pricing Authority (NPPA) has seen no reduction in maximum retail price (MRP),…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    PGIMS recalls drug amid probe into deaths

    PGIMS recalls drug amid probe into deaths

    NPPA list brings little relief: No price cut for 25% cancer drugs

    NPPA list brings little relief: No price cut for 25% cancer drugs

    Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

    Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

    For Aakash Healthcare, Community People are Apples of its Eyes

    For Aakash Healthcare, Community People are Apples of its Eyes

    Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

    Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

    Yashoda Medicity: Baby takes a Giant Step in just One Year

    Yashoda Medicity: Baby takes a Giant Step in just One Year